Free Trial

Entrada Therapeutics (TRDA) Insider Trading & Ownership

Entrada Therapeutics logo
$15.75 -0.04 (-0.25%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$16.24 +0.48 (+3.08%)
As of 05:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Entrada Therapeutics (NASDAQ:TRDA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.49%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.35M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$6.56M
Get TRDA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRDA Insider Buying and Selling by Quarter

Entrada Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/4/2026Sell25,907$15.39$398,708.73  
5/4/2026Sell15,000$15.33$229,950.00  
4/1/2026Sell2,500$12.95$32,375.00  
3/10/2026Sell11,388$13.02$148,271.76  
3/10/2026Sell11,894$13.05$155,216.70  
3/9/2026Sell5,089$13.00$66,157.00  
3/9/2026Sell3,116$13.02$40,570.32  
3/4/2026Sell7,988$12.25$97,853.00  
11/21/2025Sell8,910$9.98$88,921.80  
11/14/2025
Kush Parmar
Kush Parmar
Director
Sell200,000$8.80$1,760,000.00  
11/14/2025
Ventures V L.P. 5Am
Major Shareholder
Sell200,000$8.80$1,760,000.00  
11/12/2025
Bros. Advisors Lp Baker
Major Shareholder
Buy100,736$7.76$781,711.36  
11/11/2025
Bros. Advisors Lp Baker
Major Shareholder
Buy46,434$7.50$348,255.00  
11/10/2025
Bros. Advisors Lp Baker
Major Shareholder
Buy30,874$7.21$222,601.54  
7/9/2025
Kush Parmar
Kush Parmar
Director
Sell27,000$7.50$202,500.00  
7/9/2025
Ventures V L.P. 5Am
Major Shareholder
Sell20,065$7.50$150,487.50  
7/9/2025
Ventures V L.P. 5Am
Major Shareholder
Sell6,935$7.50$52,012.50  
6/30/2025
Kush Parmar
Kush Parmar
Director
Sell25,000$6.81$170,250.00  
6/30/2025
Ventures V L.P. 5Am
Major Shareholder
Sell18,578$6.81$126,516.18  
6/30/2025
Ventures V L.P. 5Am
Major Shareholder
Sell6,422$6.81$43,733.82  
6/27/2025
Kush Parmar
Kush Parmar
Director
Sell75,000$6.91$518,250.00  
6/27/2025
Ventures V L.P. 5Am
Major Shareholder
Sell55,735$6.91$385,128.85  
6/27/2025
Ventures V L.P. 5Am
Major Shareholder
Sell19,265$6.91$133,121.15  
(Data available from 1/1/2013 forward)

TRDA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Entrada Therapeutics includes Bioventures 2018 L.P. Mpm, Bros. Advisors Lp Baker, Dipal Doshi, Kory James Wentworth, Kush Parmar, Natarajan Sethuraman, Nathan J Dowden, Nerissa Kreher, Peter S Kim, and Ventures V L.P. 5Am. Learn more on insiders at TRDA.

9.49% of Entrada Therapeutics stock is owned by insiders. Learn more on TRDA's insider holdings.

The following insiders have purchased TRDA shares in the last 24 months: Bros. Advisors Lp Baker ($1,352,567.90), and Peter S Kim ($31,955.04).

Insiders have purchased a total of 180,320 TRDA shares in the last 24 months for a total of $1,384,522.94 bought.

The following insiders have sold TRDA shares in the last 24 months: Bioventures 2018 L.P. Mpm ($476,359.95), Dipal Doshi ($77,066.00), Kory James Wentworth ($800,227.07), Kush Parmar ($2,651,000.00), Natarajan Sethuraman ($725,069.85), Nathan J Dowden ($474,043.11), and Ventures V L.P. 5Am ($2,651,000.00).

Insiders have sold a total of 816,031 Entrada Therapeutics shares in the last 24 months for a total of $7,854,765.98 sold.



This page (NASDAQ:TRDA) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners